News & Analysis as of

Opioid Risk Management Substance Abuse

Parker Poe Adams & Bernstein LLP

Should Employers Purchase Naloxone for Emergency Use?

In recent years, we have had a number of clients report suspected employee overdoses at their facilities. The growing availability and potency of fentanyl and other opiates has resulted in an epidemic of overdoses and deaths....more

Polsinelli

Changes Coming For Prescribers To The Texas Prescription Drug Monitoring Program

Polsinelli on

In response to the opioid epidemic, many states, including Texas, created prescription drug monitoring programs to monitor high-risk patients and provider behaviors. The Texas Prescription Drug Monitoring Program (“PMP”) is...more

Nossaman LLP

Avoiding Medical Board Discipline when Prescribing Opiates

Nossaman LLP on

There is a host of new, ever changing, and conflicting guidelines from a multitude of regulators and academic societies. This evolving and uncertain landscape is making the life of a practicing pain physician in the midst of...more

K&L Gates LLP

Working Wise: Workplace Considerations Related to the Opioid Epidemic

K&L Gates LLP on

In this episode, Ryan Redekopp discusses some of the major workplace considerations related to the opioid epidemic, including potential signs that an employee might be suffering from addiction; considerations related to drug...more

Searcy Denney Scarola Barnhart & Shipley

Can Surgeon General Advisory Affect Opioid Overdoses?

Jerome Adams Calls on Communities To ‘Be Prepared’ and ‘Save A Life’ The opioid epidemic in America is so out of hand that the U.S. surgeon general’s office has issued an advisory: “Be prepared. Get naloxone. Save a life.”...more

Bricker Graydon LLP

The alarming cost of opiates in the workplace and what you can do about it

Bricker Graydon LLP on

The direct and indirect costs associated with employees’ use of drugs, including opiates, are alarming. According to the Ohio Chamber of Commerce, impaired workers are...more

Ballard Spahr LLP

Opioid Epidemic Spurs Increase in Drug Testing, Risks for Employers

Ballard Spahr LLP on

The Department of Transportation (DOT) recently added four drugs at the heart of the nation's opioid epidemic to its drug testing panels: hydrocodone, hydromorphone, oxycodone and oxymorphone—the central ingredients in such...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide